Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/26/2003EP1294681A2 Fmoc-l-leucine and derivatives thereof as ppar- gamma agonists
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294388A1 EXTRACTS FROM i SOPHORA /i SPECIES, METHOD FOR PRODUCING THE SAME AND THEIR USE
03/26/2003EP1294384A2 Use of lanthanum compounds for the treatment of bone diseases
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294372A2 Dry powder formulation comprising racecadotril
03/26/2003EP1294367A2 Oral compositions comprising host-response modulating agent
03/26/2003EP1294357A1 Bioavailable dosage form of isotretinoin
03/26/2003EP1200431B1 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
03/26/2003EP1198226B1 Mesalazine controlled release oral pharmaceutical compositions
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1027325B1 Lipophilic diesters of chelating agents
03/26/2003EP0998454B1 Metalloproteinase inhibitors
03/26/2003EP0930310B1 Isocoumarin derivatives and use thereof in drugs
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7
03/26/2003CN1406233A Medicine for viral diseases
03/26/2003CN1406227A Aryl fused azapolycy clic compounds
03/26/2003CN1406225A Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists
03/26/2003CN1405314A Cryptoporus volvatus fermented product, and its preparation method and application
03/26/2003CN1405310A Method for producing medicine using silkworm expressed numan epidermal growth factor
03/26/2003CN1405308A Method for producing medicine using silkworm expressed human alpha2b interferon
03/26/2003CN1405177A Rabdosia lophanthide extractive, natural medicine for treating hepatitis
03/26/2003CN1404875A B-type hepatitis vaccine
03/26/2003CN1404870A Chinese medicine for repairing gastric mucosa
03/26/2003CN1404865A Preparatory Chinese medicine for treating liver disease
03/26/2003CN1404859A Compound tablet of Chinese medicine for clearing out kakostomia and treating acute pharyngitis and preparation thereof
03/26/2003CN1404846A Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof
03/26/2003CN1404844A Liver-tonifying stone-removing Chinese medicine
03/26/2003CN1404838A Sodium fructose-diphosphate oral liquor for treating liver disease
03/26/2003CN1404827A 硫普罗宁制剂 Tiopronin preparations
03/26/2003CN1103750C Bioactive glass composltions and method of treatment using bioactive glass
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003WO2002026260A1 Preventives/remedies for emotional disorders
03/25/2003US6538149 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
03/25/2003US6538123 Vaccine composition for preventing or treating hepatitis C
03/25/2003US6538034 Methods of treating or preventing weight gain, obesity, and related disorders
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application
03/25/2003US6537995 Heterocyclic carboxamides
03/25/2003US6537990 Combined preparations comprising morpholine anthracyclines and anticancer agent
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537768 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens
03/25/2003US6537588 Food-induced antisecretory proteins in egg yolk
03/25/2003US6537571 Transdermal therapeutic system containing the active substance scopolamine base
03/25/2003US6537570 Method of biological control
03/25/2003US6537544 Oatmeal gruel fermiented with strains of lactobacillus plantarum JI:1 and species AC:3; prophylaxis or treatment of disturbances in equine intestinal microflora and gastritis
03/25/2003US6537543 Odorless delivery of live bacteria; uniform blend with such as lactose, ground coffee beans and lactic acid bacilli;
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/25/2003CA2423364A1 Preventives/remedies for emotional disorders
03/25/2003CA2149052C Dry mix formulation for bisphosphonic acids
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/21/2003WO2002026702A1 Phenoxyphenyl alkane sulfonates
03/21/2003WO2002026230A1 Remedies for inflammatory bowel diseases
03/21/2003CA2423423A1 Medecines of ulcerative colitis
03/21/2003CA2423171A1 Phenoxyphenyl alkane sulfonates
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003022877A1 Crystal structure of baff, and use thereof in drug design
03/20/2003WO2003022852A2 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
03/20/2003WO2003022842A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003WO2003022839A1 Tetrahydropyran derivatives and their use as therapeutic agents
03/20/2003WO2003022837A1 Heterocycle-carboxamide derivatives as raf kinase inhibitors
03/20/2003WO2003022830A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022804A2 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022291A1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
03/20/2003WO2003022273A1 Methods of treating cytokine mediated diseases
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003022271A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease
03/20/2003WO2003022259A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003WO2003022253A1 Dosage forms having prolonged active ingredient release
03/20/2003WO2003004046A3 Use of xaa-pro peptidases for the treatment of substance p-related disorders
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2003000280A3 Abin-mediated hepatitis protection
03/20/2003WO2002091993A3 Estrogen receptor modulators
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002074758A3 Novel amines as histamine-3 receptor ligands and their therapeutic applications
03/20/2003WO2002072142A3 Modulation of a balance between the gut mucosal immune system and the intestinal microflora
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002046189A3 Aryl ether substituted imidazoquinolines
03/20/2003WO2002020736A3 Proteases
03/20/2003WO2002020718A9 Osteoclast-associated receptor
03/20/2003WO2002018445A9 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
03/20/2003WO2002012245B1 Azabicyclic derivatives and their therapeutic use
03/20/2003WO2002004490A3 Lipid metabolism molecules
1 ... 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 ... 1258